文献速递乳房整形与再造

IV期乳腺癌患者的乳房重建结局

Outcomes of breast reconstruction in patients with stage IV breast cancer.
PubMed 文献 · J Plast Reconstr Aesthet Surg · 2023-04-19

基于MROC前瞻性队列数据,比较26例IV期与2613例I-III期乳腺癌患者乳房重建后的患者报告结局与并发症。IV期患者术前BREAST-Q基线评分较低,重建后评分较基线改善且与I-III期无显著差异,两组术后两年总体、主要及次要并发症率均无显著差异。

要点

  • IV期患者重建后BREAST-Q评分较基线改善,与I-III期患者无显著差异。
  • 术后两年两组总体、主要及次要并发症率均无显著差异。
  • 作者认为乳房重建可为晚期乳腺癌患者带来生活质量获益且不增加并发症,可能是合理选择。

核心结论

  • 作者认为乳房重建为晚期乳腺癌女性带来显著生活质量获益且不增加术后并发症,因而在此临床情境下可能是合理选择。

研究设计与样本

  • 基于乳房切除重建结局联盟(MROC)数据集的前瞻性队列研究,涉及美国和加拿大11家主要医疗中心。
  • 比较26例IV期乳腺癌重建患者与2613例I-III期乳腺癌重建患者,采用BREAST-Q评估患者报告结局并比较并发症。

主要发现

  • 术前IV期队列在乳房满意度(p=0.004)、心理社会健康(p=0.043)和性健康(p=0.001)的基线评分显著低于I-III期女性。
  • 乳房重建后IV期患者BREAST-Q平均评分较基线改善,且与I-III期重建患者无显著差异。
  • 重建后两年两组总体/任何并发症(p=0.782)、主要并发症(p=0.751)和次要并发症(p=0.787)率均无显著差异。

临床怎么用

  • 作者认为乳房重建可为晚期乳腺癌患者带来生活质量获益且不增加术后并发症,可能是合理选择。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Patients with Stage IV breast cancer are living longer but breast reconstruction in this setting remains controversial. There is limited research evaluating the benefits of breast reconstruction in this patient cohort. STUDY DESIGN: Drawing from the Mastectomy Reconstruction Outcomes Consortium (MROC) dataset, a prospective cohort study that involved 11 leading medical centers in the US and Canada, we compared patient-reported outcomes (PROs) assessed utilizing the BREAST-Q, a condition-specific, validated patient-reported outcome measure (PROM) for mastectomy reconstruction, as well as complications between a cohort of patients with Stage IV disease undergoing reconstruction and a control group of women with Stage I-III disease also receiving reconstruction. RESULTS: Among the MROC population, 26 patients with Stage IV and 2613 women with Stage I-III breast cancer underwent breast reconstruction. Preoperatively, the Stage IV cohort reported significantly lower baseline scores for satisfaction with breast (p = 0.004), psychosocial well-being (p = 0.043) and sexual well-being (p = 0.001), compared with Stage I-III women. Following breast reconstruction, Stage IV patients' mean PRO scores improved over baseline and were not significantly different from those of Stage I-III reconstruction patients. There were also no significant differences in overall/any (p = 0.782), major (p = 0.751) or minor complication (p = 0.787) rates between the two groups at two years following reconstruction. CONCLUSIONS: The findings in this study suggest that breast reconstruction offers significant quality-of-life benefits for women with advanced breast cancer with no increase in postoperative complications and thus may be a reasonable option in this clinical setting.

来源:J Plast Reconstr Aesthet Surg,查看原文。版权归原作者所有。

引用

  1. Hespe GE, Matusko N, Hamill JB, et al. Outcomes of breast reconstruction in patients with stage IV breast cancer. J Plast Reconstr Aesthet Surg. 2023. PMID: 37270995. doi:10.1016/j.bjps.2023.04.032

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。